The Rate of Decline in Small Fibre Function Assessed Using Axon Reflex-Mediated Neurogenic Vasodilatation and the Importance of Age Related Centile Values to Improve the Detection of Clinical Neuropathy

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Vas, Prashanth R J ^a   Rayman, Gerry ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LDIFLARE TECHNIQUE; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; NERVE FUNCTION; NEUROPATHY DISABILITY SCORE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REFLEX; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VASODILATATION;

ADULT; AGE FACTORS; AGED; AXONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FOOT; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; NERVE FIBERS; NEURAL CONDUCTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SKIN; VASODILATION;

EID: 84880769710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069920     Document Type: Article

References (29)

1. Boulton AJ, Malik RA, (2010) Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care 33: 207-209.
2. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, et al. (2006) Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29: 1294-1299.
3. Krishnan ST, Rayman G, (2004) The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 27: 2930-2935.
4. Tavakoli M, Marshall A, Pitceathly R, Fadavi H, Gow D, et al. (2009) Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol.
5. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman JS, et al. (1989) Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12: 270-275.
6. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, et al. (2003) Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60: 898-904.
7. Freeman R, Chase KP, Risk MR, (2003) Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 60: 465-470.
8. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, et al. (2010) Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 33: 1792-1797.
9. Green AQ (2010) Small fibre function assessed using the LDI flare technique in subjects with type 1 diabetes mellitus and impaired glucose tolerance. 146.
10. Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G, (2009) Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Diabetes Care 32: 451-455.
11. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW, (1998) Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 55: 1513-1520.
12. Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, et al. (2007) Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 35: 591-598.
13. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, et al. (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15: 202-207.
14. Boulton AJM, (2005) Management of Diabetic Peripheral Neuropathy. Clinical Diabetes 23: 9-15.
15. Bril V, Perkins BA, (2002) Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy. Diabetes Care 25: 2048-2052.
16. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377-384.
17. Bril V, Perkins BA, (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25: 2048-2052.
18. Vas PR, Rayman G (2012) Validation of the modified LDIFLARE technique: A simple and quick method to assess C-fiber function. Muscle Nerve.
19. Wright EM, Royston P, (1999) Calculating reference intervals for laboratory measurements. Statistical Methods in Medical Research 8: 93-112.
20. Bewick V, Cheek L, Ball J, (2004) Statistics review 13: Receiver operating characteristic curves. Critical Care 8: 508-512.
21. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, et al. (2009) Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73: 1142-1148.
22. Bravenboer B, van Dam PS, Hop J, Steenhoven J, Erkelens DW, (1992) Thermal Threshold Testing for the Assessment of Small Fibre Dysfunction: Normal Values and Reproducibility. Diabetic Medicine 9: 546-549.
23. Gibbons CH, Freeman R, Veves A, (2010) Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care 33: 2629-2634.
24. Nabavi Nouri M, Ahmed A, Bril V, Orszag A, Ng E, et al. (2012) Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One 7: e34807.
25. Green AQ, Krishnan ST, Rayman G, (2009) C-fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle Nerve 40: 985-991.
26. Green AQ, Krishnan S, Finucane FM, Rayman G, (2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33: 174-176.
27. Ebadi H, Perkins BA, Katzberg HD, Lovblom LE, Bril V, (2012) Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction. PLoS One 7: e42208.
28. Rolke R, Baron R, Maier C, Tolle TR, Treede RD, et al. (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123: 231-243.
29. Blankenburg M, Boekens H, Hechler T, Maier C, Krumova E, et al. (2010) Reference values for quantitative sensory testing in children and adolescents: developmental and gender differences of somatosensory perception. Pain 149: 76-88.